血液灌流联合血液透析治疗尿毒症难治性高血压的临床观察

Clinical observation of hemoperfusion combined with hemodialysis in the treatment of uremic patients with refractory hypertension

目的:考察血液灌流联合血液透析(HP+HD)治疗尿毒症合并难治性高血压患者的临床疗效。方法:选择尿毒症合并顽固性高血压患者60例,随机分为两组(各30例),研究组采用血液灌流联合血液透析进行治疗,对照组采用单纯血液透析进行治疗,并比较两组患者治疗情况。结果:研究组血压明显有所下降,和对照组对比差异具有统计学意义(P<0.05)。结论:血液灌流联合血液透析在治疗尿毒症合并难治性高血压方面疗效明显,值得临床推广应用。

Objective:To investigate the clinical efficacy of hemoperfusion combined with hemodialysis(HP +HD)in the treatment of uremic patients with refractory hypertension.Methods:60cases uremic patients with refractory hypertension,were randomly divided into two groups,the study group was treated by hemoperfusion combined with hemodialysis,the control group was treated by hemodialysis treatment,and compared two groups of patients with treatment.Result:Compared with the control group,the blood pressure was significantly decreased in the study group,the difference was statistically significant(P<0.05).Conclusion:Hemoperfusion combined with hemodialysis is effective in the treatment of uremia with refractory hypertension,which is worthy of clinical application.